The Ecosystem Inside You
You are not an individual. You are a habitat.
Your body contains approximately 38 trillion microbial cells — bacteria, archaea, fungi, and viruses — alongside roughly 30 trillion human cells. For decades, the ratio was described as 10:1 in favor of microbes; more recent careful estimates put it closer to 1:1. But the ratio understates the relationship. Those microbial cells carry a combined genome of approximately 20 million genes — compared to your 20,000 human genes. They weigh about 1–2 kilograms, concentrated mostly in your gut. They have been part of your biology since the moment you passed through the birth canal and were colonized by your mother's vaginal and intestinal microbes. And they are not passengers. They are co-pilots.
The human microbiome — the collective community of microorganisms living on and in the body — is now recognized as a functionally essential part of human biology. It synthesizes vitamins you can't make. It trains your immune system to distinguish friend from foe. It breaks down dietary components your own enzymes cannot touch. It communicates with your brain through a biochemical highway that influences mood, behavior, and even personality. Understanding the microbiome has upended assumptions about the self, about disease, and about what it means to be human.
Part I — The microbiome in numbers
The numbers are difficult to absorb. Your gut alone harbors somewhere between 500 and 1,000 species of bacteria, though estimates of total gut bacterial species across all humans run into the thousands. The density increases moving through the digestive tract: the stomach (highly acidic) has relatively few bacteria; the small intestine has moderate numbers; the colon is the densest microbial ecosystem on Earth — up to 10¹¹ bacteria per milliliter, more densely packed than any other known environment. By weight, the contents of your colon are roughly half microbial biomass.
The dominant bacterial phyla in the human gut are Firmicutes and Bacteroidetes, typically together comprising 90% or more of the bacterial community. The ratio between them — the Firmicutes/Bacteroidetes ratio — has been associated with obesity in some studies (obese individuals tend to have more Firmicutes), though this relationship is more complex than early reports suggested. Below the phylum level, the species composition varies dramatically between individuals — your microbiome is as unique as your fingerprint, shaped by genetics, birth mode, diet, geography, antibiotic history, and a thousand other factors.
Beyond bacteria, the gut microbiome includes archaea (primarily Methanobrevibacter smithii, which produces methane by consuming hydrogen from bacterial fermentation), fungi (the mycobiome, dominated by Candida species), and an enormous viral community — the virome — consisting primarily of bacteriophages that prey on the bacterial community. The phage community is the most poorly characterized part of the microbiome, yet it may be among the most important: phages continuously reshape the bacterial community through predation, and they can transfer genes between bacteria through transduction, potentially including antibiotic resistance genes.
Babies are born essentially sterile — the womb is a nearly microbe-free environment. Colonization begins at birth. Vaginal delivery exposes the newborn to the mother's vaginal and fecal microbes (primarily Lactobacillus and Bifidobacterium species), which rapidly colonize the infant's gut. Caesarean section babies are instead first colonized by skin and hospital environmental microbes — a different community. Studies have found differences in microbiome composition between vaginally- and C-section-delivered children that persist for years, and that C-section delivery is associated with modestly increased risk of asthma, allergies, and metabolic disorders — though whether the microbiome difference is causal remains under investigation. Breastfeeding further shapes the infant microbiome: breast milk contains not just nutrients but human milk oligosaccharides that selectively feed Bifidobacterium species, and live bacteria directly transferred from the mother's skin and milk ducts.
Part II — What your microbiome does for you
Metabolic functions
The most quantifiable microbiome functions are metabolic. Your small intestine absorbs simple sugars, amino acids, and fats with reasonable efficiency. But the colon is full of complex carbohydrates — dietary fiber — that your own digestive enzymes cannot break down. Your microbiome can. Bacteria ferment fiber into short-chain fatty acids (SCFAs) — primarily butyrate, propionate, and acetate — that serve multiple critical functions. Butyrate is the primary energy source for colonocytes (colon lining cells), providing roughly 70% of their energy. It also has anti-inflammatory and anti-cancer properties. Propionate is taken up by the liver and affects glucose metabolism and appetite regulation. Acetate circulates in the blood and affects metabolism throughout the body.
A diet low in fiber starves the bacteria that produce SCFAs. In their absence, colonocytes suffer — they essentially switch to consuming the mucus layer that lines the colon, progressively degrading the gut barrier. The consequences extend beyond digestion: SCFA deficiency is associated with increased colon cancer risk, inflammatory bowel disease, and systemic inflammation. The dramatic increase in ultra-processed food consumption in industrialized countries — foods stripped of fiber — has been accompanied by a measurable decrease in microbiome diversity and SCFA production. This is one concrete mechanism connecting diet to chronic disease through the microbiome.
Immune education
About 70% of the immune system is located in and around the gut — in the form of gut-associated lymphoid tissue (GALT) and the extensive network of immune cells in the lamina propria beneath the gut epithelium. This proximity is not coincidental: the immune system and the microbiome co-evolved, and the microbiome plays an essential role in educating the immune system during development.
Germ-free mice — raised in completely sterile conditions with no microbiome — have profoundly abnormal immune systems. Their gut-associated lymphoid tissue is underdeveloped. Their T cell populations are skewed. They are hypersusceptible to certain infections and prone to inappropriate immune responses. Colonizing them with specific bacterial species can partially rescue these defects. The microbiome provides constant low-level stimulation of immune cells, training them to respond appropriately to genuine threats while tolerating the microbial community itself and harmless food antigens. When this education fails — disrupted by antibiotic use, abnormal early colonization, or dysbiosis — the result can be allergy, autoimmunity, or inflammatory bowel disease.
In 1989, epidemiologist David Strachan published a paper noting that hay fever was less common in children from larger families — who had more contact with infections from siblings — and proposed that reduced childhood infections in smaller, more hygienic families might explain rising rates of allergic disease. This became the hygiene hypothesis, later refined into the "old friends" hypothesis by Graham Rook: the relevant factor isn't infectious diseases per se, but reduced exposure to the microbial diversity our immune systems evolved alongside — environmental microbes, parasites, and commensals rather than pathogens. The dramatic rise in allergies, asthma, inflammatory bowel disease, and autoimmune conditions in industrialized countries over the past 50 years — too fast to be genetic — is consistent with a microbiome-mediated mechanism. The developed world's microbiome is measurably less diverse than that of people living traditional lifestyles, and that diversity loss may have immunological consequences.
The gut-brain axis
The most surprising and rapidly growing area of microbiome research concerns its influence on the brain. The connection runs in both directions through multiple pathways: the vagus nerve (which directly connects the enteric nervous system of the gut to the brainstem), the immune system (gut-derived immune signals reach the brain), the endocrine system (gut bacteria produce hormones and hormone precursors), and direct production of neuroactive compounds (bacteria produce or stimulate production of serotonin, GABA, dopamine precursors, and short-chain fatty acids that cross the blood-brain barrier).
Approximately 90% of the body's serotonin is produced in the gut — not the brain — primarily by enterochromaffin cells whose activity is regulated by the microbial community. While gut serotonin doesn't directly cross the blood-brain barrier, it influences the enteric nervous system and immune cells in ways that ultimately affect brain function. Certain gut bacteria produce GABA directly; others produce short-chain fatty acids that modulate the expression of brain receptors. Metabolites from tryptophan — serotonin's precursor — are produced by gut bacteria and cross into the brain, where they affect behavior and mood.
🤔 Can changing your microbiome actually change your mood?
▼The evidence is suggestive but not yet definitive for humans. In mice, the results are striking: germ-free mice show abnormal stress responses, anxiety-like and depression-like behaviors, and reduced cognitive flexibility compared to colonized mice. Transferring the microbiome from anxious mice to calm mice transfers anxiety behaviors; the reverse transfer reduces them. In humans, clinical trials of specific probiotic strains (Lactobacillus rhamnosus, certain Bifidobacterium strains) have shown modest reductions in anxiety and depression scores in randomized controlled trials — though the effect sizes are small and not all trials replicate. A 2019 large study found significant associations between specific gut bacteria and mental health outcomes in population data. The most convincing human data comes from interventional studies: a dietary intervention (Mediterranean diet) reduced depression symptoms more effectively than social support alone in a randomized trial (the SMILES trial), with microbiome changes correlating with mood improvement. The gut-brain axis is real; the therapeutic implications are still being worked out.
Part III — When the microbiome goes wrong
Dysbiosis — disruption of the normal microbiome composition — is associated with a remarkable range of diseases. The associations span the obvious (inflammatory bowel disease, irritable bowel syndrome, colorectal cancer) to the metabolic (obesity, type 2 diabetes) to the neurological (depression, anxiety, autism spectrum disorder, Parkinson's disease) to the systemic (cardiovascular disease, rheumatoid arthritis). The list is long enough to invite skepticism — is the microbiome a universal scapegoat for every disease we don't fully understand?
The skepticism is warranted in details but not in principle. The associations are often genuinely correlational — we see microbiome differences in diseased versus healthy individuals without knowing whether the dysbiosis caused the disease, resulted from it, or is simply a coincident marker of an underlying state. Establishing causality requires intervention studies that modify the microbiome and measure disease outcomes — much harder to do rigorously than to measure associations. Where those intervention studies have been done carefully, some causal relationships have been established. The most clear-cut is C. difficile colitis: antibiotics disrupt the gut microbiome; C. diff (which is resistant) takes over; fecal microbiota transplant restores a healthy community and resolves the infection in over 90% of cases. Causality established, mechanism understood, treatment effective.
For conditions like obesity and depression, the causal chain is more complex and the clinical interventions less certain. But the evidence that the microbiome is a modifiable factor influencing these conditions — rather than a mere bystander — is growing. The field is young; the tools to study it properly (shotgun metagenomic sequencing, metabolomics, rigorous human intervention trials) have only been widely available for a decade or so. The next decade will likely substantially clarify which microbiome-disease relationships are causal and which are confounded.
"We spent most of the 20th century trying to eliminate microbes. We're spending the 21st century figuring out which ones we need."
🤔 Do probiotics actually work?
▼The answer depends critically on which probiotic, for which condition, in which population. The word "probiotic" covers an enormous range of products — specific bacterial strains with clinical trial evidence, generic yogurt with uncharacterized cultures, and everything in between. For some specific applications, specific strains have good evidence: Lactobacillus rhamnosus GG and Saccharomyces boulardii reduce the duration of antibiotic-associated diarrhea in children. Lactobacillus reuteri reduces colic in infants. Certain VSL#3 combinations reduce symptoms in ulcerative colitis. For general "immune support" or "gut health" marketed claims, the evidence is weak or absent. A significant complication: probiotic strains taken orally often don't colonize the gut long-term — they pass through. Some research suggests that conventional probiotics after antibiotics may actually slow microbiome recovery by occupying the niche and preventing native strains from recolonizing. The precision medicine approach — identifying specifically which strains are missing in a given individual and replacing exactly those — is more promising than generic multi-strain products, but requires diagnostic capabilities we don't yet routinely have.